In this study, the Patu8988 pancreatic cancer cells were given 2.5 μg/mL gemcitabine treatment for 48 h, then pancreatic CSCs markers CD24 and CD133, were detected by flow cytometry. Here, PROM1 is linked to pancreatic neoplasm.